We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.8B
AUM Growth
+$1.26B
(+2.4%)
Cap. Flow
-$756M
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
12.51%
Holding
2,394
New
190
Increased
762
Reduced
1,027
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$173M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$143M |
| 3 |
Blue Owl Capital
OWL
|
+$142M |
| 4 |
Conagra Brands
CAG
|
+$136M |
| 5 |
Lockheed Martin
LMT
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$215M |
| 2 |
PepsiCo
PEP
|
+$200M |
| 3 |
IBM
IBM
|
+$181M |
| 4 |
Merck
MRK
|
+$123M |
| 5 |
TSMC
TSM
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.62% |
| 2 | Technology | 19.5% |
| 3 | Financials | 11.8% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
F5
FFIV
$24B
| $85K | ﹤0.01% |
347
-9
| -3% | -$2K |
|
|
SCVX.WS
1727
DELISTED
SCVX Corp.
SCVX.WS
| $85K | ﹤0.01% |
250,000
| – | – |
|
1728
Ameris Bancorp
ABCB
$5.62B
| $84K | ﹤0.01% |
1,688
-37,456
| -96% | -$1.94M |
|
1729
Ball Corp
BALL
$16.2B
| $84K | ﹤0.01% |
877
-121
| -12% | -$11.2K |
|
1730
KALA BIO
KALA
$10.1M
| $84K | ﹤0.01% |
+28
| New | +$130K |
|
|
ATCX
1731
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $84K | ﹤0.01% |
9,919
+9,462
| +2,070% | +$90.8K |
|
1732
LCI Industries
LCII
$2.12B
| $83K | ﹤0.01% |
532
-699
| -57% | -$104K |
|
1733
PACCAR
PCAR
$62.2B
| $83K | ﹤0.01% |
1,403
-3,421
| -71% | -$198K |
|
1734
Whirlpool
WHR
$2.11B
| $83K | ﹤0.01% |
353
-14
| -4% | -$3.08K |
|
|
MNR
1735
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $82K | ﹤0.01% |
3,913
-3,688
| -49% | -$74.4K |
|
1736
Center Bancorp
CNOB
$1.59B
| $79K | ﹤0.01% |
2,400
-3,829
| -61% | -$126K |
|
1737
Fox Class A
FOXA
$27.8B
| $79K | ﹤0.01% |
2,131
-98
| -4% | -$3.86K |
|
|
DMRA
1738
Damora Therapeutics
DMRA
$1.51B
| $79K | ﹤0.01% |
1,040
+240
| +30% | +$18.8K |
|
1739
United Airlines
UAL
$34.5B
| $79K | ﹤0.01% |
1,797
-221,493
| -99% | -$10.3M |
|
|
FRLN
1740
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $79K | ﹤0.01% |
2,667
+667
| +33% | +$27.2K |
|
|
MTOR
1741
DELISTED
MERITOR, Inc.
MTOR
| $79K | ﹤0.01% |
+3,178
| New | +$81.1K |
|
1742
C3.ai
AI
$1.7B
| $76K | ﹤0.01% |
2,445
+2,443
| +122,150% | +$98.9K |
|
1743
AAR Corp
AIR
$4.72B
| $75K | ﹤0.01% |
1,926
+476
| +33% | +$17K |
|
1744
Alpha and Omega Semiconductor
AOSL
$747M
| $75K | ﹤0.01% |
1,237
-1,090
| -47% | -$47.2K |
|
1745
Progress Software
PRGS
$1.72B
| $75K | ﹤0.01% |
+1,555
| New | +$77.4K |
|
|
ARAV
1746
DELISTED
Aravive, Inc. Common Stock
ARAV
| $75K | ﹤0.01% |
34,372
| – | – |
|
1747
First Merchants
FRME
$2.58B
| $74K | ﹤0.01% |
1,779
-706
| -28% | -$29.6K |
|
1748
ADT
ADT
$5.14B
| $73K | ﹤0.01% |
+8,651
| New | +$73.7K |
|
1749
Amneal Pharmaceuticals
AMRX
$6.3B
| $73K | ﹤0.01% |
15,339
-17,365
| -53% | -$86.6K |
|
|
CPLG
1750
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $72K | ﹤0.01% |
4,582
-7,539
| -62% | -$119K |
|
Similar funds
Federated Hermes's Q4 2021 Portfolio in Review
As of Q4 2021, Federated Hermes held 2,394 positions worth $53.8B, up 2.4% from $52.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q4 2021 filing shows 190 new, 762 increased, 1,027 reduced and 198 closed positions. Its largest new stake was Conagra Brands: 4,144,058 shares worth $142M. The largest sale was Moderna, an estimated $215M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q4 2021 buy was Conagra Brands: 4,144,058 shares worth $142M.
- Federated Hermes added most to Bristol-Myers Squibb in Q4 2021, an estimated $173M increase.
- Federated Hermes's biggest Q4 2021 reduction was Moderna, cutting an estimated $215M.
- Federated Hermes fully exited GoDaddy in Q4 2021, selling an estimated $77.2M.
- Federated Hermes's ten largest holdings make up 13% of its $53.8B portfolio in Q4 2021.
- Federated Hermes opened 190 new positions and closed 198 in Q4 2021.
- Federated Hermes's portfolio value rose 2.4% quarter-over-quarter to $53.8B.
Based on Federated Hermes's 13F filing for Q4 2021, filed 14 Feb 2022.